Reproductive psychiatry in 2021: Old questions and new challenges
Dr. Lee S. Cohen recently shared his insights on the practice of reproductive psychiatry during the COVID-19 pandemic with ObGyn News
Treating insomnia, anxiety in a pandemic
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on treating insomnia and anxiety during pregnancy amidst the COVID-19 pandemic with Ob.Gyn News [...]
Is Suicidality on the Rise in Pregnant and Postpartum Women?
Suicide is a leading cause of maternal mortality in the United States. According to a 2017 study from California, drug-related deaths (3.68 per 100,000 person-years) and suicides (1.42 per 100,000 person-years) accounted for nearly [...]
Mitigating psychiatric disorder relapse in pregnancy during pandemic
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on mitigating psychiatric relapse during pregnancy amidst the COVID-19 pandemic with Ob.Gyn News on [...]
Why We Need Specialized Perinatal Mental Health Programs
The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression and anxiety, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a [...]
Suicide Attempts More Common During Postpartum Period, and More Lethal
A recent study from Japan uses a retrospective review of medical records to estimate the prevalence of suicide attempts among pregnant and postpartum women.
Improved Screening for Perinatal Depression and Anxiety, But What Now?
The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression and anxiety, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using [...]
New Study Estimates the Astonishing Cost of Neglected Perinatal Mood and Anxiety Disorders in US Mothers
A recently published article in the American Journal of Public Health has attributed a substantial financial cost to untreated perinatal mood and anxiety disorders among mothers. The study, conducted by researchers with the think [...]
Reproductive psychiatry during the COVID-19 pandemic
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the practice of reproductive psychiatry amidst the COVID-19 pandemic with Ob.Gyn News on [...]
Development of Zuranolone (SAGE 217) for PPD Will Move Forward
Zuranolone or SAGE-217 is similar to brexanolone (marketed as Zulresso), the medication which was FDA-approved for the treatment of postpartum depression. Zuranolone is a neurosteroid, an analogue of allopregnanolone, which is a positive allosteric [...]